Professor Arnon Kater - University of Amsterdam, The Netherlands

Professor Arnon Kater - University of Amsterdam, The Netherlands

Location: 
Davis Auditorium
Start Time: 
Wed, 02/09/2015 - 3:30pm
End Time: 
Wed, 02/09/2015 - 4:30pm

​The hunt for the right target for the treatment of chronic lymphocytic leukaemia

Special Seminar

Professor Kater trained as a hematologist at the at the Academic Medical Center, University of Amsterdam (AMC-UvA) and spent his peripheral internship at Slotervaart Hospital. In 2006 he obtained his doctorate in research into cell death regulation in CLL cells. His doctoral thesis was awarded the Fentener van Vlissingen Junior Prize. Kater has been a staff member of the Internal Medicine department at the AMC-UvA since 2007, and principal researcher in Clinical Hematology since 2012. From 2008 to 2009 he also worked as a postdoc at the Moores Cancer Centre and the Laboratory of Gene Regulation and Signal Transduction at the University of California (San Diego, US). Kater is one of the founders of the Lymphoma and Myeloma Center Amsterdam (LYMMCARE), a specialist knowledge centre where the AMC-UvA's Clinical Hematology, Experimental Immunology and Pathology departments have joined forces since 2012. Since September this year, Kater has chaired the Dutch CLL working group at the Haemato Oncology Foundation for Adults in the Netherlands (HOVON).
Kater’s fundamental, translational and clinical research as a clinical hematologist is focused on lymphatic cancer (lymphoma), particularly chronic lymphatic leukaemia (CLL). Together with colleague Professor Eric Eldering, Kater is working towards a better understanding of the cellular and molecular processes underlying the emergence and clinical behaviour of these illnesses. Many new insights are emerging in this field and rapidly leading to new treatment modalities. Over the coming years, this work will shape research and patient care at in hematology the at the AMC-UvA, particularly in the areas of lymphoma and CLL.